Quarterlytics / Healthcare / Biotechnology / Filana Therapeutics, Inc.

Filana Therapeutics, Inc.

FLNA · NASDAQ Healthcare
Claim this profile
Ticker FLNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 20

Business description

Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Austin, TX
Is this your company?
Claim profile to control your coverage, no call required.
Company facts
TickerFLNA
ExchangeNASDAQ
Sector Healthcare
Industry Biotechnology
Employees20